4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032755
See Remarks sold 4,579 shares at $60.69 ($277,902)
- See Remarks acquired 4,579 shares (option exercise)
- See Remarks acquired 432 shares (grant or award)
- See Remarks gave up 182 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Shares withheld for taxes 10b5-1 | −182 | $60.58 | $11,026 | 8,577 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Grant or award 10b5-1 | +216 | $59.07 | $12,759 | 8,793 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Grant or award 10b5-1 | +216 | 9,009 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Option exercise 10b5-1 | +4,579 | $13.56 | $62,091 | 13,588 | D |
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Sale 10b5-1 | −4,579 | $60.69 | $277,902 | 9,009 | D |
| Derivatives | |||||||
| Lyon Joseph Douglas See Remarks | 2025-02-28 | Grant or award · Stock option (right to buy) 10b5-1 | +140,000 | 140,000 | D | ||
| Lyon Joseph Douglas See Remarks | 2025-03-03 | Option exercise · Stock option (right to buy) 10b5-1 | −4,579 | 91,992 | D | ||
| Open-market sales · 4,579 sh · avg $60.69 · $277,902 | |||||||
Loading xslF345X05/ownership.xml…